Summary
- Current Price
- As of today, KYMR price is $106.41, up +0.88% on
- Current Price All-Time High
- KYMR price is currently -18.18% below its historical high of $130.05 set on
- Market Cap
- KYMR current market cap is $9B, up +206.98% over the past 365 days
- Revenue
- KYMR current annual revenue is $39.21M, down -16.70% year-over-year
- Next Earnings
- As of today, the next earnings release for KYMR has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Kymera Therapeutics, Inc. |
| Ticker | NASDAQ: KYMR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | kymeratx.com |
| Employees | 208 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $106.41 | |
| Price, 1D Change | +0.88% | |
| $9B | ||
| - | ||
| - | ||
| 0.93 | ||
| $39.21M | ||
| Revenue, 1Y Change | -16.70% | |
| -$3.69 | ||
| EPS, 1Y Change | -23.53% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.69 | ||
| EPS Estimate | -$3.51 | N/A |
| EPS Est. Change | +4.71% | N/A |
| $39.21M | ||
| Revenue Estimate | $85.39M | N/A |
| Revenue Est. Change | +117.76% | N/A |
| Current Price | $106.41 | |
| Price Target | $126.50 | - |
| Price Tgt. Change | +18.88% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.84 | -$2.98 | -5.06% | |
| -$3.47 | -$3.69 | -6.32% | |
| -$3.51 | N/A | +4.71% | |
| -$4.36 | N/A | -18.22% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $53.83M | $47.07M | -12.55% | |
| $53.64M | $39.21M | -26.90% | |
| $85.39M | N/A | +117.76% | |
| $41.09M | N/A | +4.80% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $106.41 | |
| $83.05 | ||
| $99.98 | ||
| $83.50 | ||
| $102.07 | ||
| $0.13 | ||
| 0.93 | ||
| $5.04 | ||
| 50.16 | ||
| 38.82% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $39.21M | ||
| -$3.69 | ||
| $0.00 | ||
| 78.80% | ||
| -$345.54M | ||
| -881.24% | ||
| -$311.35M | ||
| -794.04% | ||
| -$337.23M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.05 | ||
| 10.47 | ||
| 10.47 | ||
| - | ||
| 4 | ||
| 32.25 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 171.89 | ||
| 5.75 | ||
| -23.86 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $1.58B | ||
| $848.28M | ||
| $1.74B | ||
| $871.21M | ||
| $163.15M | ||
| $83.21M | ||
| $82.25M | ||
| $13.76M | ||
| $4.02M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $350.56M | ||
| $376.44M | ||
| $8.31M | ||
| $68.19M | ||
| $8.31M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$232.89M | ||
| -$521.06M | ||
| $990.71M | ||
| $1.45M | ||
| -$234.34M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Deutsche Bank | ||
| Guggenheim | → | |
| Mizuho | → | |
| RBC Capital | → | |
| B of A Securities | → | |
| Truist Securities | → | |
| B. Riley Securities | → | |
| Canaccord Genuity | → | |
| BTIG | → | |
| Canaccord Genuity |
Analyst sentiment
Institutional ownership
No data
Screeners with KYMR
FAQ
- What is the ticker symbol for Kymera Therapeutics, Inc.?
- The ticker symbol for Kymera Therapeutics, Inc. is NASDAQ:KYMR
- Does Kymera Therapeutics, Inc. pay dividends?
- No, Kymera Therapeutics, Inc. does not pay dividends
- What sector is Kymera Therapeutics, Inc. in?
- Kymera Therapeutics, Inc. is in the Healthcare sector
- What industry is Kymera Therapeutics, Inc. in?
- Kymera Therapeutics, Inc. is in the Biotechnology industry
- What country is Kymera Therapeutics, Inc. based in?
- Kymera Therapeutics, Inc. is headquartered in United States
- When did Kymera Therapeutics, Inc. go public?
- Kymera Therapeutics, Inc. initial public offering (IPO) was on August 21, 2020
- Is Kymera Therapeutics, Inc. in the S&P 500?
- No, Kymera Therapeutics, Inc. is not included in the S&P 500 index
- Is Kymera Therapeutics, Inc. in the NASDAQ 100?
- No, Kymera Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Kymera Therapeutics, Inc. in the Dow Jones?
- No, Kymera Therapeutics, Inc. is not included in the Dow Jones index
- When was Kymera Therapeutics, Inc. last earnings report?
- Kymera Therapeutics, Inc.'s most recent earnings report was on August 5, 2026
- When does Kymera Therapeutics, Inc. report earnings?
- The date for Kymera Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- KYMR Official Website www.kymeratx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1815442/000119312526073395/0001193125-26-073395-index.htm
- KYMR Profile on Yahoo Finance finance.yahoo.com/quote/KYMR
- KYMR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/kymr